You are here

  • Home
  • Archive
  • Volume 10, Issue 3
  • Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based economic evaluation

Citation Tools

Article menu

Download PDFPDF

XML
Health economics
Original research
Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based economic evaluation

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Weston G, Dombrowski C, Harvey MJ, et al
Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based economic evaluation
BMJ Open 2020;10:e031303. doi: 10.1136/bmjopen-2019-031303